Healthcare -
Medical - Healthcare Information Services - NASDAQ - US
$ 0.2467
4.8 %
$ 7.21 M
Market Cap
-0.09
P/E
1. INTRINSIC VALUE
FINANCIALS
Balance Sheet
Ontrak, Inc.
| Current Assets | 12.7 M |
| Cash & Short-Term Investments | 9.7 M |
| Receivables | 607 K |
| Other Current Assets | 2.34 M |
| Non-Current Assets | 7.2 M |
| Long-Term Investments | 0 |
| PP&E | 1.11 M |
| Other Non-Current Assets | 6.09 M |
| Current Liabilities | 3.94 M |
| Accounts Payable | 563 K |
| Short-Term Debt | 56 K |
| Other Current Liabilities | 3.32 M |
| Non-Current Liabilities | 1.63 M |
| Long-Term Debt | 1.63 M |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
Ontrak, Inc.
| Revenue | 12.7 M |
| Cost Of Revenue | 3.94 M |
| Gross Profit | 8.8 M |
| Operating Expenses | 29.5 M |
| Operating Income | -20.7 M |
| Other Expenses | 7.24 M |
| Net Income | -27.9 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ontrak, Inc.
| Net Income | -27.9 M |
| Depreciation & Amortization | 6.38 M |
| Capital Expenditures | -285 K |
| Stock-Based Compensation | 2.95 M |
| Change in Working Capital | -786 K |
| Others | 3.58 M |
| Free Cash Flow | -15.8 M |
Wall Street Analysts Price Targets
Ontrak, Inc.
OTRKP has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
0.00%
DIVIDEND YIELD
0.594 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Ontrak, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
1 year ago
Dec 20, 2023
|
Bought
31.2 M USD
|
PEIZER TERREN S
10 percent owner
|
+ 36666666
|
0.85 USD |
|
1 year ago
Dec 20, 2023
|
Bought
1.83 K USD
|
PEIZER TERREN S
10 percent owner
|
+ 18333333
|
0.0001 USD |
|
1 year ago
Nov 14, 2023
|
Bought
31.2 M USD
|
PEIZER TERREN S
10 percent owner
|
+ 36666666
|
0.85 USD |
|
1 year ago
Nov 14, 2023
|
Bought
1.83 K USD
|
PEIZER TERREN S
10 percent owner
|
+ 18333333
|
0.0001 USD |
|
1 year ago
Nov 14, 2023
|
Bought
16.2 M USD
|
PEIZER TERREN S
10 percent owner
|
+ 18054791
|
0.9 USD |
|
1 year ago
Nov 14, 2023
|
Sell 0
USD
|
PEIZER TERREN S
10 percent owner
|
- 0
|
0.9 USD |
|
1 year ago
Nov 14, 2023
|
Bought
0 USD
|
PEIZER TERREN S
10 percent owner
|
+ 0
|
0.9 USD |
|
1 year ago
Mar 06, 2023
|
Bought
4 M USD
|
PEIZER TERREN S
10 percent owner
|
+ 10000000
|
0.4 USD |
|
1 year ago
Mar 06, 2023
|
Bought
4 M USD
|
PEIZER TERREN S
10 percent owner
|
+ 8888889
|
0.45 USD |
|
3 years ago
Sep 27, 2021
|
Sell 67.2 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6813
|
9.8665 USD |
|
3 years ago
Sep 27, 2021
|
Sell 85.7 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8187
|
10.4688 USD |
|
3 years ago
Sep 28, 2021
|
Sell 139 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 13567
|
10.2283 USD |
|
3 years ago
Sep 22, 2021
|
Sell 153 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
10.2179 USD |
|
3 years ago
Sep 23, 2021
|
Sell 152 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
10.1094 USD |
|
3 years ago
Sep 24, 2021
|
Sell 144 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
9.5943 USD |
|
3 years ago
Sep 17, 2021
|
Sell 162 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
10.8033 USD |
|
3 years ago
Sep 20, 2021
|
Sell 160 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
10.6975 USD |
|
3 years ago
Sep 21, 2021
|
Sell 156 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
10.3951 USD |
|
3 years ago
Sep 14, 2021
|
Sell 164 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
10.942 USD |
|
3 years ago
Sep 15, 2021
|
Sell 158 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
10.5651 USD |
|
3 years ago
Sep 16, 2021
|
Sell 159 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
10.5743 USD |
|
3 years ago
Sep 09, 2021
|
Sell 175 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
11.6926 USD |
|
3 years ago
Sep 10, 2021
|
Sell 167 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
11.1438 USD |
|
3 years ago
Sep 13, 2021
|
Sell 165 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
10.9976 USD |
|
3 years ago
Sep 03, 2021
|
Sell 184 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
12.2489 USD |
|
3 years ago
Sep 07, 2021
|
Sell 176 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
11.716 USD |
|
3 years ago
Sep 08, 2021
|
Sell 167 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
11.1161 USD |
|
3 years ago
Aug 31, 2021
|
Sell 171 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 14433
|
11.8384 USD |
|
3 years ago
Aug 31, 2021
|
Sell 7.03 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 567
|
12.3987 USD |
|
3 years ago
Sep 01, 2021
|
Sell 180 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
11.9677 USD |
|
3 years ago
Sep 02, 2021
|
Sell 146 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 11824
|
12.3357 USD |
|
3 years ago
Sep 02, 2021
|
Sell 41.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3176
|
12.9507 USD |
|
3 years ago
Aug 27, 2021
|
Sell 168 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
11.1908 USD |
|
3 years ago
Aug 30, 2021
|
Sell 152 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 12632
|
12.0621 USD |
|
3 years ago
Aug 30, 2021
|
Sell 30.5 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2368
|
12.8831 USD |
|
3 years ago
Aug 24, 2021
|
Sell 164 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 15000
|
10.9116 USD |
|
3 years ago
Aug 25, 2021
|
Sell 159 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 13843
|
11.4544 USD |
|
3 years ago
Aug 25, 2021
|
Sell 13.7 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1157
|
11.8323 USD |
|
3 years ago
Aug 26, 2021
|
Sell 156 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 13529
|
11.519 USD |
|
3 years ago
Aug 26, 2021
|
Sell 18.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1471
|
12.2952 USD |
|
3 years ago
Aug 19, 2021
|
Sell 67.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 5664
|
11.8479 USD |
|
3 years ago
Aug 19, 2021
|
Sell 65.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4991
|
13.0366 USD |
|
3 years ago
Aug 19, 2021
|
Sell 45.2 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3215
|
14.0612 USD |
|
3 years ago
Aug 19, 2021
|
Sell 16.6 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1130
|
14.7331 USD |
|
3 years ago
Aug 20, 2021
|
Sell 20.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1938
|
10.3932 USD |
|
3 years ago
Aug 20, 2021
|
Sell 146 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 13062
|
11.1638 USD |
|
3 years ago
Aug 23, 2021
|
Sell 164 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 14770
|
11.0898 USD |
|
3 years ago
Aug 23, 2021
|
Sell 2.68 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 230
|
11.6523 USD |
|
3 years ago
Aug 16, 2021
|
Sell 304 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 13140
|
23.1634 USD |
|
3 years ago
Aug 16, 2021
|
Sell 43.8 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1860
|
23.5571 USD |
|
3 years ago
Aug 17, 2021
|
Sell 185 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8804
|
20.9623 USD |
|
3 years ago
Aug 17, 2021
|
Sell 136 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6196
|
21.9773 USD |
|
3 years ago
Aug 18, 2021
|
Sell 240 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 11311
|
21.2026 USD |
|
3 years ago
Aug 18, 2021
|
Sell 80.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3689
|
21.7259 USD |
|
3 years ago
Aug 11, 2021
|
Sell 818 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 30173
|
27.1185 USD |
|
3 years ago
Aug 11, 2021
|
Sell 282 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10411
|
27.1185 USD |
|
3 years ago
Aug 11, 2021
|
Sell 662 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 24405
|
27.1185 USD |
|
3 years ago
Aug 11, 2021
|
Sell 296 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10932
|
27.1185 USD |
|
3 years ago
Aug 11, 2021
|
Sell 235 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8676
|
27.1185 USD |
|
3 years ago
Aug 11, 2021
|
Sell 235 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8676
|
27.1185 USD |
|
3 years ago
Aug 11, 2021
|
Sell 174 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6420
|
27.1185 USD |
|
3 years ago
Jul 20, 2021
|
Sell 81.5 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2972
|
27.421 USD |
|
3 years ago
Jul 20, 2021
|
Sell 116 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4091
|
28.3036 USD |
|
3 years ago
Jul 14, 2021
|
Sell 239 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8315
|
28.783 USD |
|
3 years ago
Jul 14, 2021
|
Sell 79.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2685
|
29.4566 USD |
|
3 years ago
Jul 15, 2021
|
Sell 260 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 9400
|
27.6535 USD |
|
3 years ago
Jul 15, 2021
|
Sell 45.2 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1600
|
28.2226 USD |
|
3 years ago
Jul 19, 2021
|
Sell 220 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8063
|
27.3083 USD |
|
3 years ago
Jul 19, 2021
|
Sell 82.4 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2937
|
28.07 USD |
|
3 years ago
Jul 12, 2021
|
Sell 307 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 9978
|
30.7567 USD |
|
3 years ago
Jul 12, 2021
|
Sell 29 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 922
|
31.4879 USD |
|
3 years ago
Jul 12, 2021
|
Sell 3.24 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 100
|
32.36 USD |
|
3 years ago
Jul 13, 2021
|
Sell 327 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10900
|
30.0281 USD |
|
3 years ago
Jul 13, 2021
|
Sell 3.08 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 100
|
30.85 USD |
|
3 years ago
Jul 14, 2021
|
Sell 239 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8315
|
28.783 USD |
|
3 years ago
Jul 14, 2021
|
Sell 79.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2685
|
29.4566 USD |
|
3 years ago
Jul 07, 2021
|
Sell 315 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10477
|
30.0723 USD |
|
3 years ago
Jul 07, 2021
|
Sell 16.2 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 523
|
30.9422 USD |
|
3 years ago
Jul 08, 2021
|
Sell 50 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1700
|
29.3842 USD |
|
3 years ago
Jul 08, 2021
|
Sell 24 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 800
|
30.025 USD |
|
3 years ago
Jul 08, 2021
|
Sell 184 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 5888
|
31.3058 USD |
|
3 years ago
Jul 08, 2021
|
Sell 84.4 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2612
|
32.3142 USD |
|
3 years ago
Jul 09, 2021
|
Sell 130 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4200
|
30.9277 USD |
|
3 years ago
Jul 09, 2021
|
Sell 211 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6600
|
32.0266 USD |
|
3 years ago
Jul 09, 2021
|
Sell 6.49 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 200
|
32.46 USD |
|
3 years ago
Jul 01, 2021
|
Sell 287 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8759
|
32.7606 USD |
|
3 years ago
Jul 01, 2021
|
Sell 74.3 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2241
|
33.1561 USD |
|
3 years ago
Jul 02, 2021
|
Sell 301 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 9592
|
31.4213 USD |
|
3 years ago
Jul 02, 2021
|
Sell 45.7 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1408
|
32.4664 USD |
|
3 years ago
Jul 06, 2021
|
Sell 333 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10700
|
31.1137 USD |
|
3 years ago
Jul 06, 2021
|
Sell 9.5 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 300
|
31.6833 USD |
|
3 years ago
Jun 28, 2021
|
Sell 102 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3010
|
33.8272 USD |
|
3 years ago
Jun 28, 2021
|
Sell 165 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4740
|
34.7954 USD |
|
3 years ago
Jun 28, 2021
|
Sell 115 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3250
|
35.4229 USD |
|
3 years ago
Jun 29, 2021
|
Sell 289 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8530
|
33.8587 USD |
|
3 years ago
Jun 29, 2021
|
Sell 86.4 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2470
|
34.9742 USD |
|
3 years ago
Jun 30, 2021
|
Sell 350 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10800
|
32.4114 USD |
|
3 years ago
Jun 30, 2021
|
Sell 6.66 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 200
|
33.2998 USD |
|
3 years ago
Jun 23, 2021
|
Sell 346 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10200
|
33.8966 USD |
|
3 years ago
Jun 23, 2021
|
Sell 27.6 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 800
|
34.4857 USD |
|
3 years ago
Jun 24, 2021
|
Sell 222 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6420
|
34.6085 USD |
|
3 years ago
Jun 24, 2021
|
Sell 161 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4580
|
35.2508 USD |
|
3 years ago
Jun 25, 2021
|
Sell 323 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 9557
|
33.8195 USD |
|
3 years ago
Jun 25, 2021
|
Sell 49.9 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1443
|
34.606 USD |
|
3 years ago
Jun 18, 2021
|
Sell 286 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8321
|
34.312 USD |
|
3 years ago
Jun 18, 2021
|
Sell 94.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2679
|
35.1198 USD |
|
3 years ago
Jun 21, 2021
|
Sell 269 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8100
|
33.15 USD |
|
3 years ago
Jun 21, 2021
|
Sell 91.6 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2700
|
33.9331 USD |
|
3 years ago
Jun 21, 2021
|
Sell 7.02 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 200
|
35.125 USD |
|
3 years ago
Jun 22, 2021
|
Sell 237 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 7060
|
33.526 USD |
|
3 years ago
Jun 22, 2021
|
Sell 135 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3940
|
34.3518 USD |
|
3 years ago
Jun 15, 2021
|
Sell 268 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8332
|
32.1854 USD |
|
3 years ago
Jun 15, 2021
|
Sell 87.6 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2668
|
32.8389 USD |
|
3 years ago
Jun 16, 2021
|
Sell 194 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 5882
|
32.9406 USD |
|
3 years ago
Jun 16, 2021
|
Sell 172 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 5118
|
33.5387 USD |
|
3 years ago
Jun 17, 2021
|
Sell 150 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4493
|
33.4603 USD |
|
3 years ago
Jun 17, 2021
|
Sell 202 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 5902
|
34.2987 USD |
|
3 years ago
Jun 17, 2021
|
Sell 21.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 605
|
34.8817 USD |
|
3 years ago
Jun 10, 2021
|
Sell 66.6 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2074
|
32.1163 USD |
|
3 years ago
Jun 10, 2021
|
Sell 119 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3556
|
33.3729 USD |
|
3 years ago
Jun 10, 2021
|
Sell 101 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2970
|
34.0557 USD |
|
3 years ago
Jun 10, 2021
|
Sell 3.36 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 94
|
35.75 USD |
|
3 years ago
Jun 10, 2021
|
Sell 62 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1706
|
36.3571 USD |
|
3 years ago
Jun 10, 2021
|
Sell 22.2 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 600
|
36.9717 USD |
|
3 years ago
Jun 11, 2021
|
Sell 230 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 7398
|
31.0763 USD |
|
3 years ago
Jun 11, 2021
|
Sell 90.3 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2802
|
32.2182 USD |
|
3 years ago
Jun 11, 2021
|
Sell 26.3 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 800
|
32.8422 USD |
|
3 years ago
Jun 14, 2021
|
Sell 66.7 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2100
|
31.7654 USD |
|
3 years ago
Jun 14, 2021
|
Sell 71.4 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2200
|
32.4579 USD |
|
3 years ago
Jun 14, 2021
|
Sell 224 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6700
|
33.4045 USD |
|
3 years ago
Jun 07, 2021
|
Sell 271 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8899
|
30.5008 USD |
|
3 years ago
Jun 07, 2021
|
Sell 65.5 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2101
|
31.165 USD |
|
3 years ago
Jun 08, 2021
|
Sell 121 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3799
|
31.7723 USD |
|
3 years ago
Jun 08, 2021
|
Sell 94.2 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2900
|
32.4985 USD |
|
3 years ago
Jun 08, 2021
|
Sell 36.8 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1100
|
33.4623 USD |
|
3 years ago
Jun 08, 2021
|
Sell 185 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 5295
|
34.9205 USD |
|
3 years ago
Jun 08, 2021
|
Sell 1.27 M
USD
|
PEIZER TERREN S
Executive Chairman
|
- 35801
|
35.458 USD |
|
3 years ago
Jun 08, 2021
|
Sell 439 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 12105
|
36.2988 USD |
|
3 years ago
Jun 09, 2021
|
Sell 140 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3870
|
36.254 USD |
|
3 years ago
Jun 09, 2021
|
Sell 56.8 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1530
|
37.1482 USD |
|
3 years ago
Jun 09, 2021
|
Sell 130 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3400
|
38.2751 USD |
|
3 years ago
Jun 09, 2021
|
Sell 70.4 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1800
|
39.1306 USD |
|
3 years ago
Jun 09, 2021
|
Sell 353 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8740
|
40.3325 USD |
|
3 years ago
Jun 09, 2021
|
Sell 121 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2954
|
41.0671 USD |
|
3 years ago
Jun 02, 2021
|
Sell 158 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 5304
|
29.8356 USD |
|
3 years ago
Jun 02, 2021
|
Sell 90.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2900
|
31.0752 USD |
|
3 years ago
Jun 02, 2021
|
Sell 67.8 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2096
|
32.3469 USD |
|
3 years ago
Jun 02, 2021
|
Sell 22.9 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 700
|
32.7386 USD |
|
3 years ago
Jun 03, 2021
|
Sell 245 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 7696
|
31.8082 USD |
|
3 years ago
Jun 03, 2021
|
Sell 85.3 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2604
|
32.7602 USD |
|
3 years ago
Jun 03, 2021
|
Sell 23.4 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 700
|
33.4429 USD |
|
3 years ago
Jun 04, 2021
|
Sell 208 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6737
|
30.8942 USD |
|
3 years ago
Jun 04, 2021
|
Sell 136 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4263
|
31.8532 USD |
|
3 years ago
May 27, 2021
|
Sell 325 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10800
|
30.0592 USD |
|
3 years ago
May 27, 2021
|
Sell 6.14 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 200
|
30.72 USD |
|
3 years ago
May 28, 2021
|
Sell 236 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 7703
|
30.6614 USD |
|
3 years ago
May 28, 2021
|
Sell 103 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3297
|
31.3714 USD |
|
3 years ago
Jun 01, 2021
|
Sell 328 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 11000
|
29.8415 USD |
|
3 years ago
May 24, 2021
|
Sell 191 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6386
|
29.9682 USD |
|
3 years ago
May 24, 2021
|
Sell 143 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4614
|
30.9639 USD |
|
3 years ago
May 25, 2021
|
Sell 310 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10290
|
30.0792 USD |
|
3 years ago
May 25, 2021
|
Sell 21.8 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 710
|
30.7385 USD |
|
3 years ago
May 26, 2021
|
Sell 311 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10300
|
30.241 USD |
|
3 years ago
May 26, 2021
|
Sell 21.5 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 700
|
30.7814 USD |
|
3 years ago
May 19, 2021
|
Sell 334 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10868
|
30.6926 USD |
|
3 years ago
May 19, 2021
|
Sell 4.12 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 132
|
31.2 USD |
|
3 years ago
May 20, 2021
|
Sell 129 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4130
|
31.2715 USD |
|
3 years ago
May 20, 2021
|
Sell 220 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6870
|
32.0525 USD |
|
3 years ago
May 21, 2021
|
Sell 300 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 9390
|
31.918 USD |
|
3 years ago
May 21, 2021
|
Sell 52.2 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1610
|
32.4179 USD |
|
3 years ago
May 14, 2021
|
Sell 91.7 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3025
|
30.3163 USD |
|
3 years ago
May 14, 2021
|
Sell 69 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2200
|
31.3543 USD |
|
3 years ago
May 14, 2021
|
Sell 185 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 5775
|
32.0918 USD |
|
3 years ago
May 17, 2021
|
Sell 263 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8200
|
32.0381 USD |
|
3 years ago
May 17, 2021
|
Sell 91.5 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2800
|
32.6775 USD |
|
3 years ago
May 18, 2021
|
Sell 258 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 8077
|
31.9981 USD |
|
3 years ago
May 18, 2021
|
Sell 95 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2923
|
32.4933 USD |
|
3 years ago
May 11, 2021
|
Sell 31.6 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1099
|
28.711 USD |
|
3 years ago
May 11, 2021
|
Sell 100 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3401
|
29.4705 USD |
|
3 years ago
May 11, 2021
|
Sell 63.9 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2089
|
30.5848 USD |
|
3 years ago
May 11, 2021
|
Sell 85.4 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2700
|
31.6293 USD |
|
3 years ago
May 11, 2021
|
Sell 55.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1711
|
32.218 USD |
|
3 years ago
May 12, 2021
|
Sell 203 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6500
|
31.2745 USD |
|
3 years ago
May 12, 2021
|
Sell 144 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4500
|
31.9578 USD |
|
3 years ago
May 13, 2021
|
Sell 198 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6629
|
29.9244 USD |
|
3 years ago
May 13, 2021
|
Sell 39.5 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1271
|
31.0727 USD |
|
3 years ago
May 13, 2021
|
Sell 99 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3100
|
31.9317 USD |
|
3 years ago
May 11, 2021
|
Sell 31.6 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1099
|
28.711 USD |
|
3 years ago
May 11, 2021
|
Sell 100 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3401
|
29.4705 USD |
|
3 years ago
May 11, 2021
|
Sell 63.9 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2089
|
30.5848 USD |
|
3 years ago
May 11, 2021
|
Sell 85.4 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 2700
|
31.6293 USD |
|
3 years ago
May 11, 2021
|
Sell 55.1 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1711
|
32.218 USD |
|
3 years ago
May 12, 2021
|
Sell 203 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6500
|
31.2745 USD |
|
3 years ago
May 12, 2021
|
Sell 144 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 4500
|
31.9578 USD |
|
3 years ago
May 13, 2021
|
Sell 198 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 6629
|
29.9244 USD |
|
3 years ago
May 13, 2021
|
Sell 39.5 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 1271
|
31.0727 USD |
|
3 years ago
May 13, 2021
|
Sell 99 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 3100
|
31.9317 USD |
|
3 years ago
May 10, 2021
|
Sell 337 K
USD
|
PEIZER TERREN S
Executive Chairman
|
- 10887
|
30.92 USD |
|
3 years ago
May 10, 2021
|
Sell 2.4 M
USD
|
PEIZER TERREN S
Executive Chairman
|
- 78685
|
30.44 USD |
|
8 years ago
Aug 15, 2016
|
Bought
2.39 M USD
|
PEIZER TERREN S
Executive Chairman
|
+ 498927
|
4.8 USD |
|
7 years ago
Jan 31, 2017
|
Bought
944 K USD
|
PEIZER TERREN S
Executive Chairman
|
+ 196707
|
4.8 USD |
|
4 years ago
Jul 29, 2020
|
Bought
337 K USD
|
PEIZER TERREN S
Executive Chairman
|
+ 187002
|
1.8 USD |
|
7 years ago
Feb 17, 2017
|
Bought
296 K USD
|
PEIZER TERREN S
Executive Chairman
|
+ 61765
|
4.8 USD |
|
7 years ago
Mar 28, 2017
|
Bought
235 K USD
|
PEIZER TERREN S
Executive Chairman
|
+ 49020
|
4.8 USD |
|
7 years ago
Apr 13, 2017
|
Bought
174 K USD
|
PEIZER TERREN S
Executive Chairman
|
+ 36275
|
4.8 USD |
|
4 years ago
Apr 09, 2020
|
Bought
104 K USD
|
Rebak Robert
Director
|
+ 5000
|
20.7 USD |
|
4 years ago
Apr 09, 2020
|
Bought
104 K USD
|
Rebak Robert
Director
|
+ 5000
|
20.7 USD |
|
4 years ago
Mar 24, 2020
|
Bought
33.1 K USD
|
Rebak Robert
Director
|
+ 3200
|
10.33 USD |
|
4 years ago
Mar 16, 2020
|
Bought
20 K USD
|
Medeiros Curtis
Chief Operating Officer
|
+ 1904
|
10.5 USD |
|
4 years ago
Mar 16, 2020
|
Bought
87 K USD
|
Medeiros Curtis
Chief Operating Officer
|
+ 7561
|
11.5 USD |
|
4 years ago
Mar 16, 2020
|
Bought
93 K USD
|
Medeiros Curtis
Chief Operating Officer
|
+ 8797
|
10.5767 USD |
|
4 years ago
Mar 23, 2020
|
Bought
22.5 K USD
|
Medeiros Curtis
Chief Operating Officer
|
+ 2335
|
9.6395 USD |
|
4 years ago
Mar 23, 2020
|
Bought
88.5 K USD
|
Medeiros Curtis
Chief Operating Officer
|
+ 9500
|
9.3108 USD |
|
4 years ago
Mar 23, 2020
|
Bought
89.1 K USD
|
Medeiros Curtis
Chief Operating Officer
|
+ 10000
|
8.9079 USD |
|
4 years ago
Mar 16, 2020
|
Bought
20 K USD
|
Medeiros Curtis
Chief Operating Officer
|
+ 1904
|
10.5 USD |
|
4 years ago
Mar 16, 2020
|
Bought
87 K USD
|
Medeiros Curtis
Chief Operating Officer
|
+ 7561
|
11.5 USD |
|
4 years ago
Mar 16, 2020
|
Bought
93 K USD
|
Medeiros Curtis
Chief Operating Officer
|
+ 8797
|
10.5767 USD |
|
4 years ago
Feb 06, 2020
|
Sell 15 K
USD
|
Smith David E
|
- 796
|
18.8437 USD |
|
4 years ago
Feb 19, 2020
|
Sell 1.35 M
USD
|
Smith David E
|
- 71852
|
18.8023 USD |
|
4 years ago
Feb 06, 2020
|
Sell 15 K
USD
|
Smith David E
|
- 796
|
18.8437 USD |
|
4 years ago
Feb 05, 2020
|
Sell 475 K
USD
|
Smith David E
|
- 25256
|
18.7992 USD |
|
5 years ago
May 15, 2019
|
Sell 779 K
USD
|
Smith David E
|
- 42229
|
18.445 USD |
|
5 years ago
May 13, 2019
|
Sell 445 K
USD
|
Smith David E
10 percent owner
|
- 24500
|
18.1441 USD |
|
5 years ago
May 14, 2019
|
Sell 183 K
USD
|
Smith David E
10 percent owner
|
- 10000
|
18.27 USD |
|
5 years ago
May 09, 2019
|
Sell 279 K
USD
|
Smith David E
10 percent owner
|
- 16192
|
17.26 USD |
|
5 years ago
May 10, 2019
|
Sell 9.12 K
USD
|
Smith David E
10 percent owner
|
- 500
|
18.24 USD |
|
5 years ago
May 07, 2019
|
Sell 2.24 M
USD
|
Smith David E
10 percent owner
|
- 136138
|
16.4175 USD |
|
5 years ago
May 08, 2019
|
Sell 479 K
USD
|
Smith David E
10 percent owner
|
- 27893
|
17.1642 USD |
|
5 years ago
Apr 26, 2019
|
Sell 722 K
USD
|
Smith David E
10 percent owner
|
- 45792
|
15.7588 USD |
|
5 years ago
Apr 29, 2019
|
Sell 80.3 K
USD
|
Smith David E
10 percent owner
|
- 5023
|
15.98 USD |
|
5 years ago
Apr 24, 2019
|
Sell 862 K
USD
|
Smith David E
10 percent owner
|
- 58984
|
14.6091 USD |
|
5 years ago
Apr 25, 2019
|
Sell 1.17 M
USD
|
Smith David E
10 percent owner
|
- 76789
|
15.2755 USD |
|
5 years ago
Apr 11, 2019
|
Sell 1.37 K
USD
|
Smith David E
10 percent owner
|
- 99
|
13.88 USD |
|
5 years ago
Apr 02, 2019
|
Sell 123 K
USD
|
Smith David E
10 percent owner
|
- 8724
|
14.05 USD |
|
5 years ago
Apr 02, 2019
|
Sell 325 K
USD
|
Smith David E
10 percent owner
|
- 23090
|
14.09 USD |
|
5 years ago
Mar 25, 2019
|
Sell 225 K
USD
|
Smith David E
10 percent owner
|
- 16322
|
13.8 USD |
|
5 years ago
Mar 26, 2019
|
Sell 227 K
USD
|
Smith David E
10 percent owner
|
- 16276
|
13.92 USD |
|
5 years ago
Mar 26, 2019
|
Sell 144 K
USD
|
Smith David E
10 percent owner
|
- 10439
|
13.84 USD |
|
5 years ago
Mar 21, 2019
|
Sell 105 K
USD
|
Smith David E
10 percent owner
|
- 7543
|
13.95 USD |
|
5 years ago
Mar 22, 2019
|
Sell 1.4 K
USD
|
Smith David E
10 percent owner
|
- 100
|
13.95 USD |
|
5 years ago
Mar 19, 2019
|
Sell 73.4 K
USD
|
Smith David E
10 percent owner
|
- 5176
|
14.19 USD |
|
5 years ago
Mar 19, 2019
|
Sell 221 K
USD
|
Smith David E
10 percent owner
|
- 15596
|
14.1915 USD |
|
5 years ago
Mar 19, 2019
|
Sell 174 K
USD
|
Smith David E
10 percent owner
|
- 12355
|
14.1 USD |
|
5 years ago
Mar 19, 2019
|
Sell 211 K
USD
|
Smith David E
10 percent owner
|
- 14824
|
14.2346 USD |
|
5 years ago
Mar 15, 2019
|
Sell 159 K
USD
|
Smith David E
10 percent owner
|
- 11175
|
14.19 USD |
|
5 years ago
Mar 18, 2019
|
Sell 232 K
USD
|
Smith David E
10 percent owner
|
- 16470
|
14.11 USD |
|
6 years ago
Jun 15, 2018
|
Bought
1.84 K USD
|
GORLIN STEVE
Director
|
+ 215
|
8.57 USD |
|
6 years ago
Jun 15, 2018
|
Bought
19.8 K USD
|
GORLIN STEVE
Director
|
+ 2300
|
8.59 USD |
|
6 years ago
Jun 15, 2018
|
Bought
2.6 K USD
|
GORLIN STEVE
Director
|
+ 300
|
8.65 USD |
|
6 years ago
Jun 15, 2018
|
Bought
13.3 K USD
|
GORLIN STEVE
Director
|
+ 1550
|
8.6 USD |
|
6 years ago
Jun 15, 2018
|
Bought
864 USD
|
GORLIN STEVE
Director
|
+ 100
|
8.64 USD |
|
6 years ago
Jun 15, 2018
|
Bought
2.58 K USD
|
GORLIN STEVE
Director
|
+ 300
|
8.59 USD |
|
6 years ago
Jun 15, 2018
|
Bought
14.8 K USD
|
GORLIN STEVE
Director
|
+ 1700
|
8.68 USD |
|
6 years ago
Jun 15, 2018
|
Bought
2.59 K USD
|
GORLIN STEVE
Director
|
+ 300
|
8.63 USD |
|
6 years ago
Jun 15, 2018
|
Bought
6.08 K USD
|
GORLIN STEVE
Director
|
+ 700
|
8.69 USD |
|
6 years ago
Jun 15, 2018
|
Bought
26.1 K USD
|
GORLIN STEVE
Director
|
+ 3000
|
8.7 USD |
|
6 years ago
Jun 15, 2018
|
Bought
1.73 K USD
|
GORLIN STEVE
Director
|
+ 200
|
8.67 USD |
|
6 years ago
Jun 15, 2018
|
Bought
9.58 K USD
|
GORLIN STEVE
Director
|
+ 1100
|
8.71 USD |
|
6 years ago
Jun 15, 2018
|
Bought
863 USD
|
GORLIN STEVE
Director
|
+ 100
|
8.63 USD |
|
6 years ago
Jun 15, 2018
|
Bought
1.72 K USD
|
GORLIN STEVE
Director
|
+ 200
|
8.58 USD |
|
6 years ago
Jun 15, 2018
|
Bought
2.98 K USD
|
GORLIN STEVE
Director
|
+ 350
|
8.5 USD |
|
6 years ago
Jun 15, 2018
|
Bought
845 USD
|
GORLIN STEVE
Director
|
+ 100
|
8.45 USD |
|
6 years ago
Jun 15, 2018
|
Bought
11.8 K USD
|
GORLIN STEVE
Director
|
+ 1385
|
8.49 USD |
|
6 years ago
Jun 15, 2018
|
Bought
9.32 K USD
|
GORLIN STEVE
Director
|
+ 1100
|
8.47 USD |
|
6 years ago
Jun 15, 2018
|
Bought
976 USD
|
GORLIN STEVE
Director
|
+ 115
|
8.49 USD |
|
6 years ago
Jun 15, 2018
|
Bought
721 USD
|
GORLIN STEVE
Director
|
+ 85
|
8.48 USD |
|
6 years ago
Jun 15, 2018
|
Bought
7.61 K USD
|
GORLIN STEVE
Director
|
+ 900
|
8.46 USD |
|
6 years ago
Jun 15, 2018
|
Bought
1.69 K USD
|
GORLIN STEVE
Director
|
+ 200
|
8.45 USD |
|
6 years ago
Jun 15, 2018
|
Bought
5.1 K USD
|
GORLIN STEVE
Director
|
+ 600
|
8.5 USD |
|
6 years ago
Jun 15, 2018
|
Bought
1.69 K USD
|
GORLIN STEVE
Director
|
+ 200
|
8.47 USD |
|
6 years ago
Jun 15, 2018
|
Bought
841 USD
|
GORLIN STEVE
Director
|
+ 100
|
8.41 USD |
|
6 years ago
Jun 15, 2018
|
Bought
6.72 K USD
|
GORLIN STEVE
Director
|
+ 800
|
8.4 USD |
|
6 years ago
Jun 15, 2018
|
Bought
8.39 K USD
|
GORLIN STEVE
Director
|
+ 1000
|
8.39 USD |
|
6 years ago
Jun 15, 2018
|
Bought
838 USD
|
GORLIN STEVE
Director
|
+ 100
|
8.38 USD |
|
6 years ago
Jun 15, 2018
|
Bought
6.68 K USD
|
GORLIN STEVE
Director
|
+ 800
|
8.35 USD |
|
6 years ago
Jun 15, 2018
|
Bought
834 USD
|
GORLIN STEVE
Director
|
+ 100
|
8.34 USD |
|
6 years ago
Jun 15, 2018
|
Bought
2.38 K USD
|
GORLIN STEVE
Director
|
+ 300
|
7.95 USD |
|
6 years ago
Jun 15, 2018
|
Bought
9.49 K USD
|
GORLIN STEVE
Director
|
+ 1200
|
7.91 USD |
|
6 years ago
Jun 15, 2018
|
Bought
17.5 K USD
|
GORLIN STEVE
Director
|
+ 2200
|
7.94 USD |
|
6 years ago
Jun 15, 2018
|
Bought
4.75 K USD
|
GORLIN STEVE
Director
|
+ 600
|
7.91 USD |
|
6 years ago
Jun 15, 2018
|
Bought
4.76 K USD
|
GORLIN STEVE
Director
|
+ 600
|
7.93 USD |
|
6 years ago
Jun 15, 2018
|
Bought
792 USD
|
GORLIN STEVE
Director
|
+ 100
|
7.92 USD |
|
6 years ago
Mar 13, 2018
|
Bought
29 K USD
|
Sherman Michael Edward
Director
|
+ 6000
|
4.83 USD |
|
6 years ago
Mar 13, 2018
|
Bought
12 K USD
|
Sherman Michael Edward
Director
|
+ 2500
|
4.8 USD |
|
6 years ago
Mar 13, 2018
|
Bought
5.77 K USD
|
Sherman Michael Edward
Director
|
+ 1210
|
4.77 USD |
|
6 years ago
Mar 13, 2018
|
Bought
2.9 K USD
|
Sherman Michael Edward
Director
|
+ 609
|
4.76 USD |
|
6 years ago
Mar 13, 2018
|
Bought
4.15 K USD
|
Sherman Michael Edward
Director
|
+ 873
|
4.75 USD |
|
6 years ago
Mar 13, 2018
|
Bought
275 USD
|
Sherman Michael Edward
Director
|
+ 58
|
4.74 USD |
|
6 years ago
Mar 12, 2018
|
Bought
8.59 K USD
|
Sherman Michael Edward
Director
|
+ 1800
|
4.77 USD |
|
6 years ago
Mar 12, 2018
|
Bought
7.14 K USD
|
Sherman Michael Edward
Director
|
+ 1500
|
4.76 USD |
|
6 years ago
Mar 12, 2018
|
Bought
4.75 K USD
|
Sherman Michael Edward
Director
|
+ 1000
|
4.75 USD |
|
7 years ago
Apr 28, 2017
|
Bought
870 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 181154
|
4.8 USD |
|
8 years ago
Aug 15, 2016
|
Bought
78.8 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 71591
|
1.1 USD |
|
9 years ago
Jul 30, 2015
|
Bought
0 USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 0
|
1.9 USD |
|
9 years ago
Jul 30, 2015
|
Bought
1.78 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 935008
|
1.9 USD |
|
8 years ago
Mar 30, 2016
|
Bought
212 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 450000
|
0.47 USD |
|
8 years ago
Jul 05, 2016
|
Bought
105 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 318182
|
0.33 USD |
|
8 years ago
May 24, 2016
|
Bought
101 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 306818
|
0.33 USD |
|
8 years ago
Apr 27, 2016
|
Bought
94 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 200000
|
0.47 USD |
|
8 years ago
Jun 22, 2016
|
Bought
62.5 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 189394
|
0.33 USD |
|
8 years ago
Jun 02, 2016
|
Bought
57.5 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 174242
|
0.33 USD |
|
8 years ago
Jul 21, 2016
|
Bought
37.5 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 113636
|
0.33 USD |
|
9 years ago
Oct 16, 2015
|
Bought
287 K USD
|
Smith David E
director, 10 percent owner:
|
+ 956667
|
0.3 USD |
|
9 years ago
Oct 16, 2015
|
Bought
90 K USD
|
GORLIN STEVE
Director
|
+ 300000
|
0.3 USD |
|
9 years ago
Oct 16, 2015
|
Bought
1.62 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 5410000
|
0.3 USD |
|
9 years ago
Sep 17, 2015
|
Bought
463 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 1543334
|
0.3 USD |
|
10 years ago
Dec 22, 2014
|
Bought
300 K USD
|
GORLIN STEVE
Director
|
+ 150000
|
2 USD |
|
10 years ago
Dec 23, 2014
|
Bought
140 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 70000
|
2 USD |
|
10 years ago
May 27, 2014
|
Bought
200 K USD
|
Smith David E
10 percent owner
|
+ 344828
|
0.58 USD |
|
10 years ago
May 27, 2014
|
Bought
200 K USD
|
Smith David E
10 percent owner
|
+ 344828
|
0.58 USD |
|
10 years ago
May 27, 2014
|
Bought
1.21 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 2077587
|
0.58 USD |
|
10 years ago
May 27, 2014
|
Bought
1.21 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 2077587
|
0.58 USD |
|
10 years ago
Jan 31, 2014
|
Bought
920 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 1585345
|
0.58 USD |
|
10 years ago
Jan 31, 2014
|
Bought
920 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 1585345
|
0.58 USD |
|
11 years ago
Oct 15, 2013
|
Bought
500 K USD
|
Smith David E
10 percent owner
|
+ 862069
|
0.58 USD |
|
11 years ago
Oct 15, 2013
|
Bought
500 K USD
|
Smith David E
10 percent owner
|
+ 862069
|
0.58 USD |
|
11 years ago
Oct 15, 2013
|
Bought
2 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 3448276
|
0.58 USD |
|
11 years ago
Oct 15, 2013
|
Bought
2 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 3448276
|
0.58 USD |
|
11 years ago
Apr 10, 2013
|
Bought
228 K USD
|
Smith David E
10 percent owner
|
+ 3257143
|
0.07 USD |
|
11 years ago
Apr 10, 2013
|
Bought
228 K USD
|
Smith David E
10 percent owner
|
+ 3257143
|
0.07 USD |
|
11 years ago
Apr 10, 2013
|
Bought
1.21 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 17300000
|
0.07 USD |
|
11 years ago
Apr 10, 2013
|
Bought
1.21 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 17300000
|
0.07 USD |
|
12 years ago
Dec 04, 2012
|
Bought
2.5 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 35714286
|
0.07 USD |
|
12 years ago
Dec 04, 2012
|
Bought
2.5 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 35714286
|
0.07 USD |
|
12 years ago
Dec 04, 2012
|
Bought
500 K USD
|
Smith David E
10 percent owner
|
+ 7142858
|
0.07 USD |
|
12 years ago
Sep 13, 2012
|
Bought
981 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 9810000
|
0.1 USD |
|
12 years ago
Sep 13, 2012
|
Bought
981 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 9810000
|
0.1 USD |
|
12 years ago
Apr 17, 2012
|
Bought
1.75 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 10965050
|
0.16 USD |
|
12 years ago
Apr 17, 2012
|
Bought
1.75 M USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 10965050
|
0.16 USD |
|
13 years ago
Dec 27, 2011
|
Bought
166 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 553290
|
0.3 USD |
|
13 years ago
Dec 28, 2011
|
Sell 118 K
USD
|
PEIZER TERREN S
Chairman & CEO
|
- 393334
|
0.3 USD |
|
13 years ago
Dec 27, 2011
|
Bought
166 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 553290
|
0.3 USD |
|
13 years ago
Dec 28, 2011
|
Sell 118 K
USD
|
PEIZER TERREN S
Chairman & CEO
|
- 393334
|
0.3 USD |
|
13 years ago
Dec 08, 2011
|
Bought
0 USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 0
|
0.26 USD |
|
13 years ago
Dec 08, 2011
|
Bought
55.4 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 173077
|
0.32 USD |
|
12 years ago
Feb 22, 2012
|
Bought
975 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 3250000
|
0.3 USD |
|
12 years ago
Feb 22, 2012
|
Bought
0 USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 0
|
0.3 USD |
|
13 years ago
Nov 30, 2011
|
Bought
0 USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 0
|
0.26 USD |
|
13 years ago
Nov 30, 2011
|
Bought
289 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 903847
|
0.32 USD |
|
13 years ago
Nov 15, 2011
|
Bought
0 USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 0
|
0.26 USD |
|
13 years ago
Nov 15, 2011
|
Bought
197 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 615385
|
0.32 USD |
|
13 years ago
Nov 02, 2011
|
Bought
0 USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 0
|
0.26 USD |
|
13 years ago
Nov 02, 2011
|
Bought
197 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 615385
|
0.32 USD |
|
13 years ago
Aug 17, 2011
|
Bought
0 USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 0
|
0.26 USD |
|
13 years ago
Aug 17, 2011
|
Bought
800 K USD
|
PEIZER TERREN S
Chairman & CEO
|
+ 2500000
|
0.32 USD |
|
13 years ago
Sep 02, 2011
|
Bought
80 USD
|
Smith David E
10 percent owner
|
+ 250
|
0.32 USD |
|
13 years ago
Sep 01, 2011
|
Bought
146 USD
|
Smith David E
10 percent owner
|
+ 457
|
0.32 USD |
|
13 years ago
Mar 17, 2011
|
Bought
1.78 M USD
|
Smith David E
10 percent owner
|
+ 4452081
|
0.4 USD |
|
13 years ago
Oct 05, 2011
|
Bought
0.26 USD
|
Smith David E
10 percent owner
|
+ 1
|
0.26 USD |
|
13 years ago
Oct 05, 2011
|
Bought
0.32 USD
|
Smith David E
10 percent owner
|
+ 1
|
0.32 USD |
|
13 years ago
Oct 05, 2011
|
Bought
0.32 USD
|
Smith David E
10 percent owner
|
+ 1
|
0.32 USD |
|
13 years ago
Oct 05, 2011
|
Bought
0.26 USD
|
Smith David E
10 percent owner
|
+ 1
|
0.26 USD |
|
14 years ago
Nov 12, 2010
|
Bought
171 K USD
|
Wolf Jay
Director
|
+ 17121585
|
0.01 USD |
|
14 years ago
Nov 12, 2010
|
Bought
28.8 K USD
|
Wolf Jay
Director
|
+ 2878415
|
0.01 USD |
|
15 years ago
Apr 15, 2009
|
Sell 12.9 K
USD
|
CUMMINS MARC G
Director
|
- 45556
|
0.2839 USD |
|
15 years ago
Apr 16, 2009
|
Sell 22.6 K
USD
|
CUMMINS MARC G
Director
|
- 80000
|
0.2825 USD |
|
15 years ago
Apr 17, 2009
|
Sell 4.76 K
USD
|
CUMMINS MARC G
Director
|
- 16410
|
0.29 USD |
|
16 years ago
Oct 17, 2008
|
Sell 220 K
USD
|
PEIZER TERREN S
Chief Executive Officer
|
- 200000
|
1.1 USD |
|
16 years ago
Jul 09, 2008
|
Bought
6.3 K USD
|
TIMPE CHUCK
Chief Financial Officer
|
+ 2603
|
2.42 USD |
|
16 years ago
Apr 22, 2008
|
Bought
179 K USD
|
CUMMINS MARC G
Director
|
+ 99700
|
1.8 USD |
|
16 years ago
Apr 22, 2008
|
Bought
538 USD
|
CUMMINS MARC G
Director
|
+ 300
|
1.795 USD |
|
17 years ago
Nov 07, 2007
|
Bought
1.5 M USD
|
CUMMINS MARC G
Director
|
+ 260960
|
5.75 USD |
|
16 years ago
Apr 14, 2008
|
Bought
82.4 K USD
|
CUMMINS MARC G
Director
|
+ 47096
|
1.75 USD |
|
16 years ago
Apr 14, 2008
|
Bought
870 USD
|
CUMMINS MARC G
Director
|
+ 500
|
1.74 USD |
|
16 years ago
Apr 14, 2008
|
Bought
173 USD
|
CUMMINS MARC G
Director
|
+ 100
|
1.73 USD |
|
16 years ago
Apr 14, 2008
|
Bought
3.94 K USD
|
CUMMINS MARC G
Director
|
+ 2304
|
1.71 USD |
|
16 years ago
Apr 09, 2008
|
Bought
14.7 K USD
|
CUMMINS MARC G
Director
|
+ 8400
|
1.75 USD |
|
16 years ago
Apr 09, 2008
|
Bought
72.4 K USD
|
CUMMINS MARC G
Director
|
+ 41600
|
1.74 USD |
|
16 years ago
Apr 04, 2008
|
Bought
67.2 K USD
|
CUMMINS MARC G
Director
|
+ 37546
|
1.79 USD |
|
16 years ago
Apr 04, 2008
|
Bought
35.1 K USD
|
CUMMINS MARC G
Director
|
+ 19700
|
1.78 USD |
|
16 years ago
Apr 04, 2008
|
Bought
2.48 K USD
|
CUMMINS MARC G
Director
|
+ 1400
|
1.77 USD |
|
16 years ago
Apr 04, 2008
|
Bought
3.79 K USD
|
CUMMINS MARC G
Director
|
+ 2152
|
1.76 USD |
|
16 years ago
Apr 04, 2008
|
Bought
348 USD
|
CUMMINS MARC G
Director
|
+ 200
|
1.74 USD |
|
16 years ago
Apr 04, 2008
|
Bought
13.6 K USD
|
CUMMINS MARC G
Director
|
+ 7749
|
1.75 USD |
|
16 years ago
Apr 04, 2008
|
Bought
2.08 K USD
|
CUMMINS MARC G
Director
|
+ 1200
|
1.73 USD |
|
16 years ago
Apr 02, 2008
|
Bought
171 K USD
|
PEIZER TERREN S
Chief Executive Officer
|
+ 100000
|
1.71 USD |
|
16 years ago
Apr 02, 2008
|
Bought
30.2 K USD
|
CUMMINS MARC G
Director
|
+ 19900
|
1.52 USD |
|
16 years ago
Apr 02, 2008
|
Bought
22.8 K USD
|
CUMMINS MARC G
Director
|
+ 15085
|
1.51 USD |
|
16 years ago
Apr 02, 2008
|
Bought
15.2 K USD
|
CUMMINS MARC G
Director
|
+ 10115
|
1.5 USD |
|
16 years ago
Apr 02, 2008
|
Bought
2.96 K USD
|
CUMMINS MARC G
Director
|
+ 2000
|
1.48 USD |
|
17 years ago
Jan 03, 2008
|
Bought
11.3 K USD
|
TIMPE CHUCK
Chief Financial Officer
|
+ 4539
|
2.49 USD |
|
17 years ago
Jul 09, 2007
|
Bought
13.7 K USD
|
TIMPE CHUCK
Chief Financial Officer
|
+ 1864
|
7.35 USD |
|
17 years ago
Jul 09, 2007
|
Bought
8.66 K USD
|
Sabnani Sanjay
Executive Vice President
|
+ 1178
|
7.35 USD |
|
17 years ago
Feb 09, 2007
|
Bought
7.46 K USD
|
TIMPE CHUCK
Chief Financial Officer
|
+ 1617
|
4.6155 USD |
|
17 years ago
Feb 09, 2007
|
Bought
5.22 K USD
|
Sabnani Sanjay
Senior Vice President
|
+ 1132
|
4.6155 USD |
7. News
Ontrak, Inc. (OTRK) Q3 2024 Earnings Call Transcript
Ontrak, Inc. (NASDAQ:OTRK ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Ryan Halsted - Investor Relations, Gilmartin Group Brandon LaVerne - Chief Executive Officer & Chief Operating Officer Mary Lou Osborne - President & Chief Commercial Officer James Park - Chief Financial Officer Conference Call Participants Operator Thank you for standing by. Welcome to the Ontrak Health Third Quarter 2024 Earnings Call.
seekingalpha.com
- 2 months ago
Ontrak, Inc. (OTRK) Reports Q3 Loss, Lags Revenue Estimates
Ontrak, Inc. (OTRK) came out with a quarterly loss of $1.77 per share versus the Zacks Consensus Estimate of a loss of $1.56. This compares to loss of $24.14 per share a year ago.
zacks.com
- 2 months ago
Ontrak Health Announces 2024 Third Quarter Financial Results
MIAMI--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and technology-enabled behavioral healthcare company, today reported its financial results for the third quarter ended September 30, 2024. Management Commentary Brandon LaVerne, Ontrak Health's Chief Executive Officer, stated, “I am thrilled that we have now secured two new regional health plan customers and four health plan expansions since January of this year, spanning a range of plan types,.
businesswire.com
- 2 months ago
Ontrak, Inc. (OTRK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Ontrak (OTRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.com
- 2 months ago
Ontrak Health Expands Behavioral Health Solutions with Sentara Health Plans for Commercial and Marketplace Populations
MIAMI--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK), a leading AI-powered and telehealth-enabled behavioral healthcare company, today announced a continuing expansion of its strategic partnership with Sentara Health Plans in the Commonwealth of Virginia. Ontrak is thrilled to be expanding services with Sentara Health Plans, the health plan division of Sentara Health, an integrated, not-for-profit health care delivery system. This expansion represents a dual expansion of its Engage solution, a c.
businesswire.com
- 2 months ago
Ontrak Health to Report 2024 Third Quarter Financial Results on November 13, 2024
MIAMI--(BUSINESS WIRE)--Ontrak Health (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the third quarter 2024 on Wednesday, November 13, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in inf.
businesswire.com
- 2 months ago
Ontrak Announces Receipt of Notice from Nasdaq Regarding Non-Compliance of its 9.50% Series A Cumulative Perpetual Preferred Stock with Minimum Bid Price Requirement
HENDERSON, Nev.--(BUSINESS WIRE)--On April 13, 2023, Ontrak, Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company no longer meets the minimum bid price requirement set forth in Nasdaq Listing Rule 5555(a)(1) (the “Minimum Bid Price Requirement”) because the closing bid price for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Preferred Stock”) was less than $1.00 for the previous 30 consecutive business days. The Notice has no immediate effect on the listing of the Company’s Preferred Stock on The Nasdaq Global Market. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a 180-calendar day grace period, or until October 10, 2023 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. The Minimum Bid Price Requirement will be met if the Company’s Preferred Stock has a minimum closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during the 180-calendar day grace period, unless Nasdaq exercises its discretion to extend such 10-day period. If the Company does not regain compliance by the Compliance Date, the Company may be eligible for an additional 180-calendar day compliance period, subject to satisfying the conditions in the applicable Nasdaq Listing Rules. The Company is monitoring the closing bid price of its Preferred Stock and will consider options to regain compliance with the Minimum Bid Price Requirement. However, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement. The Series A Preferred Stock trades on NASDAQ Global Market under the symbol “OTRKP.” About Ontrak, Inc. Ontrak, Inc. is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.
businesswire.com
- 1 year ago
Ontrak Announces Receipt of Notice from Nasdaq Regarding Non-Compliance of its 9.50% Series A Cumulative Perpetual Preferred Stock with Minimum Bid Price Requirement
HENDERSON, Nev.--(BUSINESS WIRE)--(NASDAQ: OTRK) (NASDAQ: OTRKP) – On December 6, 2022, Ontrak, Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company no longer meets the minimum bid price requirement set forth in Nasdaq Listing Rule 5460(a)(3) (the “Minimum Bid Price Requirement”) because the closing bid price for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Preferred Stock”) was less than $1.00 for the previous 30 consecutive business days. The Notice has no immediate effect on the listing of the Preferred Stock on The Nasdaq Global Market. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a 180-calendar day grace period, or until June 5, 2023 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. The Minimum Bid Price Requirement will be met if the Preferred Stock has a minimum closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during the 180-calendar day grace period, unless Nasdaq exercises its discretion to extend such 10-day period. If the Company does not regain compliance by the Compliance Date, the Company may be eligible for an additional 180-calendar day compliance period, subject to satisfying the conditions in the applicable Nasdaq Listing Rules. The Company is monitoring the closing bid price of the Preferred Stock and will consider options to regain compliance with the Minimum Bid Price Requirement. However, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement. The Series A Preferred Stock trades on NASDAQ Global Market under the symbol “OTRKP.” About Ontrak, Inc. Ontrak, Inc. is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors. Learn more at www.ontrakhealth.com.
businesswire.com
- 2 years ago
Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock
SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (NASDAQ: OTRKP) (“Ontrak” or the “Company”) today announced that its Board of Directors has declared the fifth quarterly cash dividend for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”). The fifth quarterly cash dividend equals $0.593750 per share, at 9.50% per annum of liquidation preference of $25.00 per share. The Series A Preferred Stock dividend will be payable on November 30, 2021 to holders of record as of the close of business on November 15, 2021, provided that if any dividend payment date is not a business day, then the dividend that would otherwise have been payable may be paid on the next succeeding business day and no interest, additional dividends or other sums will accrue on the amount so payable for the period from and after the dividend payment date to that next succeeding business day. The Series A Preferred Stock trades on NASDAQ Global Market under the symbol “OTRKP.” For additional information, visit https://www.ontrakhealth.com. About Ontrak, Inc. Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors. Learn more at www.ontrakhealth.com
businesswire.com
- 3 years ago
Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock
SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (NASDAQ: OTRKP) (“Ontrak” or the “Company”) today announced that its Board of Directors has declared the fourth quarterly cash dividend for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”). The fourth quarterly cash dividend equals $0.593750 per share, at 9.50% per annum of liquidation preference of $25.00 per share. The Series A Preferred Stock dividend will be payable on August 31, 2021 to holders of record as of the close of business on August 15, 2021, provided that if any dividend payment date is not a business day, then the dividend that would otherwise have been payable may be paid on the next succeeding business day and no interest, additional dividends or other sums will accrue on the amount so payable for the period from and after the dividend payment date to that next succeeding business day. The Series A Preferred Stock trades on NASDAQ Global Market under the symbol “OTRKP.” For additional information, visit https://www.ontrak-inc.com. About Ontrak, Inc. Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors. Learn more at www.ontrak-inc.com.
businesswire.com
- 3 years ago
Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock
SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (NASDAQ: OTRKP) (“Ontrak” or the “Company”) today announced that its Board of Directors has declared the third quarterly cash dividend for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”). The third quarterly cash dividend equals $0.593750 per share, at 9.50% per annum of liquidation preference of $25.00 per share. The Series A Preferred Stock dividend will be payable on May 30, 2021 to holders of record as of the close of business on May 15, 2021, provided that if any dividend payment date is not a business day, then the dividend that would otherwise have been payable may be paid on the next succeeding business day and no interest, additional dividends or other sums will accrue on the amount so payable for the period from and after the dividend payment date to that next succeeding business day. The Series A Preferred Stock trades on NASDAQ Global Market under the symbol “OTRKP.” For additional information, visit https://www.ontrak-inc.com About Ontrak, Inc. Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and telehealth enabled, virtualized healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The company’s PRE™ (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages people who are not getting the care they need. By combining predictive analytics with human engagement, Ontrak delivers improved member health and validated outcomes and savings to healthcare payers. The company’s integrated, technology-enabled Ontrak™ programs, a critical component of the PRE platform, are designed to provide healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs. Ontrak has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance. Ontrak integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health, including loneliness. The company’s programs improve member health and deliver validated cost savings to healthcare payers of between 40 and 50 percent of enrolled members. Learn more at www.ontrak-inc.com
businesswire.com
- 3 years ago
Ontrak Announces 2020 Fourth Quarter and Year End Financial Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized healthcare company, today reported its financial results for the fourth quarter and year ended December 31, 2020. Management Commentary “While we are extremely disappointed by the upcoming loss of our Ontrak-A contract in June 2021, we are focused on the growth opportunities ahead of us with existing and new customers," said Terren Peizer, Ontrak Chairman and CEO. “During the fourth quarter, expanded programs with existing health plans and signed contract renewals with current customers resulted in strong enrollment rates which we expect to see continue through 2021. The tailwinds to our financial performance as we enter 2021 are: Very rapid enrollment of members under our Ontrak-CI contract, which expanded in October 2020 and already tops 5,100 members. A severe shortage of quality behavioral health providers which has heightened the value of our contractual relationships with over 11,600 high quality behavioral health providers whom we train and from whom we receive valuable member progress reports. We anticipate this number to grow to approximately 15,000 in Q2, resulting in the largest qualified behavioral health provider network in the industry. Continued momentum in our pipeline and expansions driven by health plan customer confidence in our member engagement, evidence-based care programs and proven savings and associated ROI. Our other existing customers besides Ontrak-A have either already signed extensions or expansions with us, or are expected to in the next month. Record high member satisfaction levels demonstrated by an industry leading Q4 2020 Net Promoter Score of 80 for our Ontrak program versus an NPS of 74 in Q3 2020. The anticipated 2021 launch of Ontrak tiered care programs for the full spectrum of behavioral health needs from high to low acuity, designed to meet 100% of the behavioral health needs of those with undiagnosed and untreated behavioral health conditions. The anticipated 2021 launch of an expanded suite of digital programs including mobile-first depression and anxiety modules that build upon the LifeDojo platform and scale our ability to serve more members in the rapidly growing behavioral health marketplace. Recently signed contract expansions for LifeDojo solutions with a subsidiary of Berkshire Hathaway and Dolby.” Mr. Peizer continued, “As a market leader in telemental health with a high-quality network of over 11,600 behavioral health provider contractual relationships in 40 states plus Washington DC, Ontrak is uniquely positioned to deliver positive and durable outcomes for not only care avoidant but also care neutral and care seeking members of our health plan partners. We have a total addressable market opportunity of over $30 billion.” Fourth Quarter 2020 Financial Results Highlights Revenue for the fourth quarter of 2020 was $29.3 million, representing a 149% increase compared to the same period in 2019 and a 22% increase from the prior quarter. Operating loss for the fourth quarter of 2020 was $(1.8) million, yielding an operating loss margin of (6)% compared to an operating loss of $(7.0) million for the same period in 2019, yielding an operating loss margin of (60)%. Operating loss improved 39% from an operating loss of $(3.0) million in the third quarter of 2020. Adjusted EBITDA for the fourth quarter of 2020 was $2.2 million compared to adjusted EBITDA of $(4.6) million for the same period in 2019. Adjusted EBITDA improved sequentially by an average of $1.7 million in each of the quarters in 2020. Net loss for the fourth quarter of 2020 was $(3.2) million, or a $(0.27) diluted net loss per common share (after deduction for declared and undeclared preferred stock dividends), compared to net loss of $(8.7) million, or a $(0.52) diluted net loss per share for the same period in 2019. Net loss and diluted net loss per common share improved 43% and 25% from net loss of $(5.7) million and $(0.36) diluted net loss per share in the third quarter of 2020, respectively. Non-GAAP net income for the fourth quarter of 2020 was $0.3 million, or a $(0.07) non-GAAP diluted net loss per common share (after deduction for declared and undeclared preferred stock dividends), compared to non-GAAP net loss of $(6.4) million, or a $(0.39) non-GAAP diluted net loss per share for the same period in 2019. Non-GAAP net loss and non-GAAP diluted net loss per common share improved 109% and 65% from $(2.9) million non-GAAP net loss and $(0.20) non-GAAP diluted net loss per common share in the third quarter of 2020, respectively. Fiscal Year 2020 Financial Results Highlights Revenue for the full year of 2020 was $82.8 million, representing a 136% increase from prior year. Operating loss for the full year of 2020 was $(14.9) million, yielding an operating loss margin of (18)% compared to an operating loss of $(20.0) million for the prior year, yielding an operating loss margin of (57)%. Adjusted EBITDA for the full year of 2020 was $(4.3) million compared to adjusted EBITDA of $(12.9) million for the prior year. Net loss for the full year of 2020 was $(22.7) million, or a $(1.44) diluted net loss per common share (after deduction for declared and undeclared preferred stock dividends), compared to net loss of $(25.7) million, or a $(1.56) diluted net loss per share for the prior year. Non-GAAP net loss for the full year of 2020 was $(12.0) million, or a $(0.82) non-GAAP diluted net loss per common share (after deduction for declared and undeclared preferred stock dividends), compared to non-GAAP net loss of $(18.9) million, or a $(1.15) non-GAAP diluted net loss per share for the prior year. Fourth Quarter 2020 and Recent Operating Highlights: Total enrolled members, including Ontrak-A members, increased to 15,702 at the end of Q4 2020 and to 15,524 as of the date of this release. Gross enrollment for the two-month period ended February 28, 2021, excluding the Ontrak-A customer, was 2,683, reflecting a 60% annualized enrollment rate. The Company renewed its contract with one of the nation's leading health insurance providers for its Ontrak-C solution in Texas. The Company launched Ontrak-CI Program for a national health plan in 13 states for the three-year contract awarded in June. The Company launched a new 3-year partnership with the Veterans Health Administration to transform suicide prevention care in the U.S. The Company raised $44.9 million ($41.4 million net of underwriting fees and other offering expenses) through the issuance of 1,815,265 of 9.50% Series A Cumulative Perpetual Preferred Stock ("Series A Preferred Stock"). The non-convertible Series A Preferred Stock trades on the Nasdaq Global Market under the symbol "OTRKP." The Company's Board of Directors appointed Robert I. Newton as its General Counsel and Secretary. Financial Outlook The following outlook is based on information available as of the date of this press release and is subject to change in the future. This outlook solely represents existing and planned enrollment launches, and program expansions with current health plan partners. For the year ending December 31, 2021, the Company provides the following outlook: Revenue of $100 million. Initially, we were going to guide to 100% growth with revenues of $165 million. In light of Ontrak-A, we believe we are being conservative with our $100 million revenue guidance. Of that number, over $88 million is from customers with existing contracts or in the signature phase and those health plan partners remaining with us are already contemplating further expansions. Moreover, we see tremendous upside with large plans in our pipeline. Furthermore, we are continuing to develop our strategy to regain the Ontrak-A business emphasizing our validated medical cost savings and ROI, our NPS of 80, and our clinical outcomes. Conference Call & Webcast Details The Company will host a conference call/webcast today at 4:30 pm ET/1:30 pm PT. Investors, analysts, employees and the general public can access the call by dialing (833) 519-1269 for U.S. participants or (914) 800-3841 for international participants, and referencing conference ID #4174875. A live and archived webcast of the event will be available at https://www.ontrak-inc.com/investors.html. About Ontrak, Inc. Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and telehealth enabled, virtualized healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The company’s PRE™ (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages people who are not getting the care they need. By combining predictive analytics with human engagement, Ontrak delivers improved member health and validated outcomes and savings to healthcare payers. The company’s integrated, technology-enabled Ontrak™ programs, a critical component of the PRE platform, are designed to provide healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs. Ontrak has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance. Ontrak integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health, including loneliness. The company’s programs improve member health and deliver validated cost savings to healthcare payers of between 40 and 50 percent for enrolled members. Learn more at www.ontrak-inc.com Forward-Looking Statements Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward looking statements may include for example statements regarding: growth and market opportunities; expansions with existing customers for new contracts and renewals; rapid enrollment rates; tailwinds, including statements of our expectations related to rapid enrollment under our Ontrak-CI contract, growth in, and value of, our provider contractual relationships, momentum in our pipeline and expansions and related health plan customers’ confidence in our programs and proven savings and associated ROI, the effect of our record high member satisfaction levels, the anticipated 2021 launch of our Ontrak tiered care programs and their ability to meet the needs of 100% of those with undiagnosed and untreated behavioral health conditions, the anticipated 2021 launch of an expanded suite of behavioral health programs and their scalability to serve more members, and recently signed contract expansions for our LifeDojo solutions; and statements regarding revenue growth in 2021 and our strategy to regain the Ontrak-A business. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations; limited operating history; our inability to execute our business plan; increase our revenue and achieve profitability; lower than anticipated eligible members under our contracts; our inability to recognize revenue; lack of outcomes and statistically significant formal research studies; difficulty enrolling new members and maintaining existing members in our programs; the risk that the treatment programs might not be effective; difficulty in developing, exploiting and protecting proprietary technologies; intense competition and substantial regulation in the health care industry; business disruption and related risks resulting from the outbreak of the novel coronavirus 2019; high customer concentration; dependence on key personnel and the ability to recruit, retain and develop a large and diverse workforce; the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern; our ability to raise additional capital when needed and our liquidity; and risks related to our ability to realize the potential benefits of and to effectively integrate acquisitions. You are urged to consider statements that include the words “may,” “will,” “could,” “should,” “believes,” “estimates,” “projects,” “potential,” “expects,” “plan,” “anticipates,” “intends,” “continues,” “forecast,” “designed,” “goal,” or the negative of those words or other comparable words to be uncertain and forward-looking. Forward looking statements may include statements regarding potential additional spending on behavioral health, our path towards profitability, our momentum, anticipation of 2020 headwinds becoming 2021 tailwinds, surging demand for “telemental” health services, revenue from new launches, nationwide contracts upon which to expand, significant progress towards contracting with our increasing pipeline of potential partners, our confidence in our growth strategy for 2021 and beyond, and our outlook for future revenues and Adjusted EBITDA. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at http://www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Non-GAAP Financial Measures To supplement its consolidated financial statements, which are prepared and presented in accordance with U.S. generally accepted accounting principles, or GAAP, the Company has provided in this press release and the quarterly conference call held on the date hereof certain non-GAAP financial measures. The non-GAAP financial measures presented include EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net loss, and Non-GAAP net loss per common share, which are not U.S. GAAP financial measures, and clarifies and enhances an understanding of our past performance. We believe that the presentation of these financial measures enhances an investor’s understanding of our financial performance. We further believe that these financial measures are useful financial metrics to assess our operating performance from period-to-period by excluding certain items that we believe are not representative of our core business. EBITDA consists of net loss before interest, taxes, depreciation and amortization expenses. Adjusted EBITDA consists of net loss before interest, taxes, depreciation, amortization, stock-based compensation, acquisition related costs, (gain) loss on change in fair value of warrant liability and write-off of debt issuance costs. We believe that making such adjustments provides investors meaningful information to understand our results of operations and the ability to analyze our financial and business trends on a period-to-period basis. Non-GAAP net loss consists of net loss adjusted for stock-based compensation, acquisition related costs, (gain) loss on change in fair value of warrant liability and write-off of debt issuance costs. Non-GAAP net loss per common share consists of loss per share adjusted for non-GAAP net loss attributable to common stockholders. We believe that making such adjustments provides investors meaningful information to understand our results of operations and the ability to analyze our financial and business trends on a period-to-period basis. We believe the above non-GAAP financial measures are commonly used by investors to evaluate our performance and that of our competitors. However, our use of the term EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net loss and Non-GAAP net loss per common share may vary from that of others in our industry. Neither EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net loss nor Non-GAAP net loss per common share should be considered as an alternative to net loss before taxes, net loss, net loss per common share or any other performance measures derived in accordance with U.S. GAAP as measures of performance. ONTRAK, INC. Consolidated Statements of Operations (in thousands, except per share data) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Revenue $ 29,251 $ 11,758 $ 82,837 $ 35,095 Cost of revenue 13,426 6,897 43,603 20,408 Gross profit 15,825 4,861 39,234 14,687 Operating expenses: Research and development 4,908 1,463 12,923 5,439 Sales and marketing 1,423 1,286 4,525 4,735 General and administrative 11,318 9,109 36,709 24,527 Total operating expenses 17,649 11,858 54,157 34,701 Operating loss (1,824 ) (6,997 ) (14,923 ) (20,014 ) Other income (expense), net 13 (21 ) (1,213 ) (2,598 ) Interest expense, net (2,063 ) (1,665 ) (7,219 ) (3,047 ) Loss before income taxes (3,874 ) (8,683 ) (23,355 ) (25,659 ) Income tax benefit 645 — 645 — Net loss (3,229 ) (8,683 ) (22,710 ) (25,659 ) Dividends on preferred stock - declared and undeclared (1,523 ) — (1,987 ) — Net loss attributable to common stockholders $ (4,752 ) $ (8,683 ) $ (24,697 ) $ (25,659 ) Net loss per common share - basic and diluted $ (0.27 ) $ (0.52 ) $ (1.44 ) $ (1.56 ) Weighted-average common shares outstanding - basic and diluted 17,472 16,590 17,112 16,418 ONTRAK, INC. Consolidated Balance Sheets (in thousands, except share and per share data) December 31, 2020 2019 Assets Current assets: Cash and cash equivalents $ 86,907 $ 13,610 Restricted cash - current 9,127 — Receivables, net 16,682 3,615 Unbilled receivables 4,426 2,093 Deferred costs - current 2,352 341 Prepaid expenses and other current assets 4,144 733 Total current assets 123,638 20,392 Long-term assets: Property and equipment, net 2,273 528 Restricted cash - long-term 7,176 408 Goodwill 5,727 — Intangible assets, net 3,561 — Other assets 367 112 Operating lease right-of-use asset 1,959 2,415 Total assets $ 144,701 $ 23,855 Liabilities and stockholders' equity (deficit) Current liabilities: Accounts payable $ 1,287 $ 1,385 Accrued compensation and benefits 4,723 3,640 Deferred revenue 20,954 5,803 Current portion of operating lease liability 434 374 Other accrued liabilities 9,012 2,205 Warrant liabilities — 691 Total current liabilities 36,410 14,098 Long-term liabilities: Long-term debt, net 45,719 31,597 Long-term operating lease liability 1,403 1,836 Long-term finance lease liabilities 418 233 Total liabilities 83,950 47,764 Commitments and contingencies Stockholders' deficit: Preferred stock, $0.0001 par value; 50,000,000 shares authorized; 3,770,265 and no shares issued and outstanding at December 31, 2020 and 2019, respectively — — Common stock, $0.0001 par value, 500,000,000 shares authorized; 17,543,218 and 16,616,165 shares issued and outstanding at December 31, 2020 and 2019, respectively 2 2 Additional paid-in capital 414,773 307,403 Accumulated deficit (354,024 ) (331,314 ) Total stockholders' equity (deficit) 60,751 (23,909 ) Total liabilities and stockholders' equity (deficit) $ 144,701 $ 23,855 ONTRAK, INC. Consolidated Statements of Cash Flows (in thousands ) Year Ended December 31, 2020 2019 Cash flows from operating activities Net loss $ (22,710 ) $ (25,659 ) Adjustments to reconcile net loss to net cash used in operating activities: Stock-based compensation expense 8,126 5,210 Write-off of debt issuance costs — 1,505 Paid-in-kind interest expense 3,500 — Depreciation 303 133 Amortization 1,624 696 Deferred taxes (654 ) — Warrants issued for services — 43 Change in fair value of warrants 1,233 60 Change in fair value of contingent consideration (20 ) — 401(k) employer match in common shares 691 — Deferred rent — (26 ) Changes in operating assets and liabilities: Receivables (13,014 ) (2,233 ) Unbilled receivables (2,333 ) (2,093 ) Prepaid and other assets (5,677 ) (246 ) Accounts payable (175 ) 888 Deferred revenue 15,057 1,608 Lease liabilities (373 ) 684 Other accrued liabilities 8,140 2,529 Net cash used in operating activities (6,282 ) (16,901 ) Cash flows from investing activities Purchases of property and equipment (1,757 ) — Acquisition of LifeDojo, net of cash acquired (2,881 ) — Net cash used in investing activities (4,638 ) — Cash flows from financing activities Proceeds from issuance of preferred stock 87,359 — Preferred stock issuance costs (806 ) — Dividends paid (1,241 ) — Proceeds from revolving loan — 7,500 Repayment of revolving loan — (15,000 ) Proceeds from A/R facility — 36,527 Repayment of A/R facility — (1,938 ) Proceeds from loan 10,000 1,938 Debt issuance costs (128 ) (2,813 ) Debt termination related fees — (1,956 ) Proceed from warrant exercise 133 1,128 Proceed from options exercise 6,171 1,894 Finance lease obligations (186 ) 69 Financed insurance premium payments (1,190 ) — Net cash provided by financing activities 100,112 27,349 Net change in cash and restricted cash 89,192 10,448 Cash and restricted cash at beginning of period 14,018 3,570 Cash and restricted cash at end of period $ 103,210 $ 14,018 Supplemental disclosure of cash flow information: Interest paid $ 2,961 $ 870 Right of use asset obtained in exchange for lease obligation — 2,574 Non-cash financing and investing activities: Stock issued in acquisition of LifeDojo $ 5,035 $ — Financed insurance premiums 3,344 — Warrant issued in connection with 2024 Note — 2,354 Reclassification of warrant liability to equity 1,924 86 Finance lease and accrued purchases of property and equipment 500 250 Contingent consideration and cash holdback relating to acquisition of LifeDojo 605 — ONTRAK, INC. Reconciliation of Non-GAAP Measures (in thousands, except per share data) Reconciliation of Operating Loss to EBITDA and Adjusted EBITDA Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Operating Loss $ (1,824 ) $ (6,997 ) $ (14,923 ) $ (20,014 ) Depreciation expense 125 25 303 133 Amortization expense (1) 392 138 874 246 EBITDA (1,307 ) (6,834 ) (13,746 ) (19,635 ) Stock-based compensation expense 2,327 2,263 8,126 5,210 Write-off of debt issuance costs (2) — — — 1,505 Acquisition related costs (3) 1,153 — 1,329 — Adjusted EBITDA $ 2,173 $ (4,571 ) $ (4,291 ) $ (12,920 ) Adjusted EBITDA Margin 7 % (39 )% (5 )% (37 )% Reconciliation of Net Loss to Non-GAAP Net Income (Loss); and Net Loss per Common Share to Non-GAAP Net Loss per Common Share Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Net loss $ (3,229 ) $ (8,683 ) $ (22,710 ) $ (25,659 ) Stock-based compensation expense 2,327 2,263 8,126 5,210 Loss on change in fair value of warrant liability 16 22 1,233 60 Write-off of debt issuance costs (2) — — — 1,505 Acquisition related costs (3) 1,153 — 1,329 — Non-GAAP net income (loss) $ 267 $ (6,398 ) $ (12,022 ) $ (18,884 ) Dividends on preferred stock - declared and undeclared (1,523 ) — (1,987 ) — Non-GAAP net loss attributable to common stockholders $ (1,256 ) $ (6,398 ) $ (14,009 ) $ (18,884 ) Net loss per common share - basic and diluted $ (0.27 ) $ (0.52 ) $ (1.44 ) $ (1.56 ) Non-GAAP net loss per common share - basic and diluted (0.07 ) (0.39 ) (0.82 ) (1.15 ) Weighted-average common shares outstanding - basic and diluted 17,472 16,590 17,112 16,418 __________________________ (1) Relates to operating and financing ROU assets and acquired intangible assets. (2) Relates to the repayment and termination of our 2022 Loan in September 2019. (3) Includes external legal, accounting, and advisory costs, as well as gain on change in fair value of continent liability related to a stock price guarantee, associated with an acquisition.
businesswire.com
- 3 years ago
8. Profile
Summary
Ontrak, Inc. OTRKP
COUNTRY
US
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 7.21 M
Dividend Yield
0.00%
Description
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Henderson, Nevada.
Contact
2200 Paseo Verde Parkway, Henderson, NV, 89052
https://www.ontrak-inc.com
IPO
Date
Aug. 28, 2020
Employees
102
Officers
Dr. Judith Feld M.D., M.P.H.
Chief Medical Officer
Mr. James J. Park
Chief Financial Officer & Principal Accounting Officer
Ms. Susan E. Etzel CPA
Senior Vice President of Finance & Assistant Secretary
Mr. Brandon H. LaVerne CPA
Chief Executive Officer
Ms. Lori Wheeless
Senior Vice President of Digital Services Operations
Ms. Mary Louise Elizabeth Osborne
President & Chief Commercial Officer
Ms. Sandy Gyenes
Senior Vice President of Human Resources
Ms. Brianna Brennan
Chief Innovation Officer
Mr. Arik Hill
Chief Information Officer
Ms. Sunmi Janicek
Chief Compliance & Privacy Officer